BioVie Inc.
BIVI | NASDAQ
$1.43
+$0.05 (+3.62%)
At close: Oct 30, 2026, 4:00 PM ET
$1.43
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 229.38K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -229.38K | n/a | n/a | n/a | n/a |
Operating Income | -22.65M | -18.07M | -32.18M | -45.08M | -27.25M | -138.05M |
Interest Income | 596.77K | 853.03K | 1.14M | 562.26K | 44.08K | 21.97K |
Pretax Income | -22.07M | -17.54M | -32.12M | -50.26M | -26.08M | -130.25M |
Net Income | -22.07M | -17.54M | -32.12M | -50.26M | -26.08M | -130.25M |
Selling & General & Admin | 8.51M | 8.57M | n/a | 11.55M | n/a | n/a |
Research & Development | 13.96M | 9.27M | 23.1M | 33.3M | 17.26M | 133.19M |
Other Expenses | 178.34K | n/a | 9.08M | 229.38K | 9.99M | 4.87M |
Operating Expenses | 22.65M | 17.84M | 32.18M | 45.08M | 27.25M | 138.05M |
Interest Expense | 17.9K | 332.72K | 2.89M | 4.3M | 2.16M | 559.46K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.65M | 18.07M | 32.18M | 45.08M | 27.25M | 138.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7.25M | 1.48M | 451.85K | 324.83K | 246.63K | 124.03K |
Shares Outstanding (Diluted) | 7.25M | 1.48M | 451.85K | 324.83K | 246.63K | 124.03K |
EPS (Basic) | -3.05 | -12.12 | -73.05 | -154.70 | -106 | -1.48K |
EPS (Diluted) | -3.05 | -12.12 | -73.05 | -154.70 | -106 | -1.48K |
EBITDA | -21.88M | -16.98M | -29M | -45.73M | -23.69M | -129.46M |
EBIT | -22.05M | -17.21M | -29.23M | -45.96M | -23.92M | -129.69M |
Depreciation & Amortization | 178.34K | 229.38K | 229.38K | 229.38K | 229.38K | 230K |
Add to Watchlist
Select watchlists to add or remove BIVI